Starpharma Holdings Limited has released a press release.
DEP milestone triggers partner option fee
Earlier from Starpharma
- Positive DEP HER2-Lu preclinical data support Phase 1 entry
- FDA confirms path to DEP HER2 first-in-human study
- Half Yearly Report and Accounts
- Quarterly Activities/Appendix 4C Cash Flow Report